Investor's Business Daily on MSN10h
Biotech Stocks Take A Tariffs Hit. Pharmaceuticals Are Exempt — For Now.Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...
Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback